Replies to post #169696 on Bioelectronics Corp (BIEL)

[ddls]

ActiPatch has NOT proved itself to be "highly effective"

Marginally effective at best in all the small study groups done. Let them do some studies with a larger study groups (if they had the money) in the 500 patient range.

Here's the policy the FDA should adopt for junk from small companies like BIEL. Let the companies products on the market for two year period. Can't hurt if the device obviously harmless due to the small watch battery it uses.

Here's another problem problem with sports injuries. There are no two injuries exactly the same, so how can an accurate study be done? It can't! Just let the device on the market and see how consumers accept it. Either the company profits, or the company dies.

Here's another thing with the ActiPatch knee patch. BIEL shows someone jogging with it on! LOL, if one were smart one would not be jogging if their knee was injured and was painful. LOL